Literature DB >> 6135443

beta-Adrenergic receptor subtypes and intraocular pressure.

A Rushton.   

Abstract

Mesh:

Substances:

Year:  1983        PMID: 6135443      PMCID: PMC1040120          DOI: 10.1136/bjo.67.8.557

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  7 in total

1.  The role of beta 2-adrenoceptors in the IOP-lowering effect of adrenaline.

Authors:  H C Innemee; P A van Zwieten
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1982       Impact factor: 3.117

2.  The effects of adrenergic agonists and antagonists on the adenylate cyclase in albino rabbit ciliary processes.

Authors:  J Cepelík; M Cernohorský
Journal:  Exp Eye Res       Date:  1981-03       Impact factor: 3.467

3.  Effects of a potent and specific beta 2-adrenoceptor antagonist on intraocular pressure.

Authors:  J A Nathanson
Journal:  Br J Pharmacol       Date:  1981-05       Impact factor: 8.739

4.  Adrenergic regulation of intraocular pressure: identification of beta 2-adrenergic-stimulated adenylate cyclase in ciliary process epithelium.

Authors:  J A Nathanson
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

5.  Beta adrenergic receptors in pigmented ciliary processes.

Authors:  G E Trope; B Clark
Journal:  Br J Ophthalmol       Date:  1982-12       Impact factor: 4.638

6.  Human ciliary process adrenergic receptor: pharmacological characterization.

Authors:  J A Nathanson
Journal:  Invest Ophthalmol Vis Sci       Date:  1981-12       Impact factor: 4.799

7.  Initial and long-term effects of metoprolol and timolol on the intraocular pressure. A comparison in healthy subjects.

Authors:  A Alm; C P Wickström; P Törnquist
Journal:  Acta Ophthalmol (Copenh)       Date:  1981-08
  7 in total
  1 in total

1.  Beta-adrenergic receptor subtypes iris-ciliary body of rabbits.

Authors:  B Clark; G E Trope; S J Titinchi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1985       Impact factor: 3.117

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.